title: Use of calcium channel blockers in prostate cancer: Friends or foe?
authors.affiliation: Department of Cardiology, Liaocheng People's Hospital and Clinical School of Taishan Medical University, Liaocheng 252000, PR China.
authors.forename: Qian-Feng
authors.initials: QF
authors.lastname: Han
authors.affiliation: Department of Orthopedics, Liaocheng People's Hospital and Clinical School of Taishan Medical University, Shandong Province, Liaocheng 252000, PR China.
authors.forename: Xiao-Feng
authors.initials: XF
authors.lastname: Ren
authors.affiliation: Department of Cardiology, Liaocheng People's Hospital and Clinical School of Taishan Medical University, Liaocheng 252000, PR China.
authors.forename: Lei
authors.initials: L
authors.lastname: Wu
authors.affiliation: Department of Cardiology, Liaocheng People's Hospital and Clinical School of Taishan Medical University, Liaocheng 252000, PR China.
authors.forename: Tai
authors.initials: T
authors.lastname: Li
authors.affiliation: Department of Cardiology, Liaocheng People's Hospital and Clinical School of Taishan Medical University, Liaocheng 252000, PR China. Electronic address: yaohc66@126.com.
authors.forename: Heng-Chen
authors.initials: HC
authors.lastname: Yao
mesh_terms: D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms; D011634:Public Health; D018570:Risk Assessment / Q000379:methods*
chemical_list: D002121:Calcium Channel Blockers
keywords: Calcium channel blockers; Prostate cancer